Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Gains from Investment Securities (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Gains from Investment Securities readings, the most recent being $10.3 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 175.18% to $10.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.3 million, a 175.18% increase, with the full-year FY2025 number at $10.3 million, up 175.18% from a year prior.
  • Gains from Investment Securities hit $10.3 million in Q4 2025 for Lucid Diagnostics, up from $9.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $10.3 million in Q4 2025 to a low of $275424.0 in Q2 2024.
  • Median Gains from Investment Securities over the past 5 years was $1.5 million (2025), compared with a mean of $3.4 million.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 86.35% in 2024 and later soared 2143.48% in 2025.
  • Lucid Diagnostics' Gains from Investment Securities stood at $1.4 million in 2021, then skyrocketed by 80.76% to $2.6 million in 2022, then soared by 114.56% to $5.5 million in 2023, then plummeted by 32.18% to $3.7 million in 2024, then skyrocketed by 175.18% to $10.3 million in 2025.
  • The last three reported values for Gains from Investment Securities were $10.3 million (Q4 2025), $9.9 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.